ReviewCurrent drug discovery technologies2026
Unraveling Vitiligo: A Multifactorial, Autoimmune Disease - An Insight into its Pathophysiology and Power of Herbal Healing.
Review in Current drug discovery technologies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vitiligo, also known as leukoderma, is a chronic autoimmune skin disorder characterized by the progressive loss of melanocytes, leading to depigmented patches on the skin. While it is not life-threatening, the visible nature of the condition can significantly impact a patient's psychological and emotional well-being. This review aimed to provide a comprehensive overview of vitiligo, including its clinical presentation, pathogenesis, diagnostic methods, and current therapeutic options. Although various synthetic treatments are available, ranging from corticosteroids to phototherapy, their long-term effectiveness is often limited, and adverse effects are more common. As a result, there is a growing interest in natural and plant-based therapies that may offer safer and more sustainable alternatives. This review has highlighted the use of herbal bioactives and traditional medicines for vitiligo management, drawing upon the data sourced from PubMed, Google Scholar, Springer, and ClinicalTrials.gov databases. Key search terms for this review included vitiligo, herbal therapies, traditional medicine, animal models, Shwitra, and Baras. The review has also explored findings from animal models and clinical trials, contributing to our understanding of disease mechanisms and therapeutic efficacy. By integrating traditional knowledge with modern research, there is emerging potential for plant-derived compounds to serve as complementary or alternative options in vitiligo treatment. In conclusion, advancing our understanding of vitiligo's underlying mechanisms and embracing safer, evidence-based herbal therapies may pave the way toward more effective and holistic patient care.
Indexed as
Identifiers
41102965What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.